Vida Pharmacal is developing solutions for diagnosing and treating emerging and neglected diseases in animals and humans. Lead assets will include the first FDA/CVM-approved treatment for Chagas disease in canines and felines, as well as the first USDA-approved diagnostic test to identify Chagas disease in canines and felines. Additional diagnostic and therapeutic targets include detection and treatment products for Leishmania in canines and felines.